This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MDCO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Revolution Medicines’ Innovative RAS(ON) Platform and Strategic Collaborations Drive Buy RatingAugust 8 at 5:44 AM | tipranks.comBeOne Medicines Ltd (SHSE:688235) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ...August 7 at 10:34 AM | gurufocus.comQ2 2025 BeOne Medicines AG Earnings Call TranscriptAugust 7 at 8:35 AM | gurufocus.comRevolution Medicines (RVMD) Highlights Key Progress in RAS(ON) Inhibitor PipelineAugust 7 at 6:58 AM | gurufocus.comDecoding BeOne Medicines Ltd (ONC): A Strategic SWOT InsightAugust 6 at 12:15 AM | gurufocus.comRevolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate ProgressAugust 6 at 5:13 PM | gurufocus.comBeOne Medicines (ONC) Reports Strong Q2 Growth, Updates 2025 Revenue GuidanceAugust 6 at 2:13 PM | gurufocus.comBeOne Medicines Announces Second Quarter 2025 Financial Results and Business UpdatesAugust 6 at 6:18 AM | financialpost.comFPraxis Precision Medicines’ Positive Earnings Call Highlights Vormatrigine SuccessAugust 5, 2025 | tipranks.comTango Therapeutics Doses First Patient in Combination Trial of TNG462 and Revolution Medicines RAS(ON) Inhibitors and Reports Q2 2025 Financial ResultsAugust 5, 2025 | quiverquant.comQPraxis Precision Medicines Inc (PRAX) Q2 2025 Earnings Call Highlights: Vormatrigine Shows ...August 5, 2025 | gurufocus.comPraxis Precision Medicines Reports Promising Study ResultsAugust 4, 2025 | tipranks.comPraxis Precision Medicines Inc (PRAX) Announces CEO's Participation in Virtual Fireside Chat | ...August 4, 2025 | gurufocus.comDecoding Praxis Precision Medicines Inc (PRAX): A Strategic SWOT InsightAugust 4, 2025 | gurufocus.comQ2 2025 Praxis Precision Medicines Inc Earnings Call TranscriptAugust 4, 2025 | gurufocus.comPraxis Precision Medicines Inc (PRAX) Announces CEO's Participation in Virtual Fireside Chat | ...August 4, 2025 | gurufocus.comPraxis Precision Medicines to Participate in Upcoming Fireside Chat | PRAX Stock NewsAugust 4, 2025 | gurufocus.comPromising Potential of Praxis Precision Medicines: Buy Rating Affirmed by Douglas TsaoAugust 4, 2025 | tipranks.comTYK Medicines Completes H Share Placement to Fuel R&D and GrowthAugust 4, 2025 | tipranks.comKingworld Medicines Group Ltd. Announces New Board CompositionAugust 3, 2025 | tipranks.comKingworld Medicines Announces Board ChangesAugust 3, 2025 | tipranks.comEverest Medicines Expands U.S. Presence with Strategic Investment in I-MabAugust 1, 2025 | tipranks.comEverest Medicines Completes Share Placement and Raises HK$1.55 BillionAugust 1, 2025 | tipranks.comBeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s MacroglobulinemiaJuly 31, 2025 | financialpost.comFPfizer’s (PFE) Breakthrough Medicines Power its Dividend StabilityJuly 30, 2025 | insidermonkey.comGSK Lifts Outlook As Specialty Medicines, Vaccines Fuel GrowthJuly 30, 2025 | benzinga.comGSK's Specialty Medicines Shows Potential for GrowthJuly 30, 2025 | gurufocus.comTariffs on Medicines From Europe Stand to Cost Drugmakers BillionsJuly 28, 2025 | nytimes.comBeOne Medicines' Tevimbra gets CHMP endorsementJuly 28, 2025 | seekingalpha.comBeOne Medicines stock rises after positive EU opinion for lung cancer drugJuly 28, 2025 | investing.comBeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC TreatmentJuly 28, 2025 | financialpost.comFBeOne Medicines Ltd. (ONC) Wins EU Nod for TevimbraJuly 25, 2025 | insidermonkey.comEU regulator approves injectable HIV drug that experts say could help stop transmissionJuly 25, 2025 | financialpost.comFEU regulator approves injectable HIV drug that experts say could help stop transmissionThe European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV...July 25, 2025 | marketbeat.comRevolution Medicines Inc (RVMD) Unveils Breakthrough in Targeted Cancer Therapy | RVMD stock newsJuly 24, 2025 | gurufocus.comTYK Medicines’ Cancer Treatments Gain Recognition at ESMO Congress 2025July 24, 2025 | tipranks.comImmunityBio’s (IBRX) ANKTIVA Gets Approved by UK’s Medicines and Healthcare Regulatory AgencyJuly 23, 2025 | insidermonkey.comPress Release: Trahan and Colleagues Introduce Legislation to Ensure Access to FDA-Approved MedicinesJuly 18, 2025 | quiverquant.comQBlueprint Medicines' (BPMC) Ayvakit Faces Competition from Cogent Biosciences | BPMC Stock NewsJuly 18, 2025 | gurufocus.comBlueprint Medicines Completes $9.1B Merger, Delists from NasdaqJuly 18, 2025 | tipranks.comRevolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman SachsJuly 17, 2025 | finance.yahoo.comBlueprint Medicines' SWOT analysis: stock poised for growth amid challengesJuly 17, 2025 | investing.comBeOne Medicines (ONC) Sees Price Target Boost by JP Morgan | ONC Stock NewsJuly 17, 2025 | gurufocus.comPraxis Precision Medicines Gains FDA Breakthrough DesignationJuly 17, 2025 | tipranks.comRevolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman SachsJuly 16, 2025 | insidermonkey.comBeOne Medicines to Announce Q2 2025 Financial ResultsJuly 16, 2025 | tipranks.com3D Medicines Inc. Strengthens Stability with Strategic AgreementJuly 14, 2025 | tipranks.comValneva’s Chikungunya Vaccine Restriction Lifted by EMAJuly 11, 2025 | tipranks.comBeOne Medicines (ONC) Gains EU Approval for Tevimbra in Cancer TherapyJuly 10, 2025 | gurufocus.comKingworld Medicines Clarifies 2025 Share Award Scheme DetailsJuly 10, 2025 | tipranks.com Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.000.38▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼216▲MDCO Articles Average Week Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News Today CORT News Today JAZZ News Today PRGO News Today SUPN News Today PCRX News Today NKTR News Today OMER News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDCO Stock Alerts